Significant and Meaningful Improvement in Treatment Satisfaction with Teriflunomide Versus Subcutaneous IFNB-1A in Patients with Relapsing MS Results from Tenere
Value Health
.
2014 Nov;17(7):A403.
doi: 10.1016/j.jval.2014.08.927.
Epub 2014 Oct 26.
Authors
M Mäurer
1
,
B Van Wijmeersch
2
,
J de Seze
3
,
J Meca-Lallana
4
,
S Bozzi
5
,
P Vermersch
6
Affiliations
1
Caritas Krankenhaus Bad Mergentheim, Bad Mergentheim, Germany.
2
Hasselt University, Diepenbeek, Belgium.
3
Strasbourg University, Strasbourg, France.
4
Universidad Católica San Antonio de Murcia, Murcia, Spain.
5
Sanofi, Chilly-Mazarin, France.
6
University of Lille Nord de France, Lille, France.
PMID:
27200967
DOI:
10.1016/j.jval.2014.08.927
No abstract available